ArticleCancer medicine2024

CRAFITY score benefits hepatocellular carcinoma patients treated with transarterial chemoembolization and lenvatinib.

Lin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.